Assessing Interventions to Increase Tdap Acceptance for Non-birthing Partners in Pregnancy
Recruiting
Phase 4
Interventional Study
Non-birthing Partner Vaccination in Pregnancy
Tdap - Tetanus, Diphtheria and Acellular Pertussis Vaccination
Vaccine Exposure During Pregnancy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 19 – 50
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 150 (estimated)
- Sponsor
- Women and Infants Hospital of Rhode Island · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this randomized control trial is to assess if prenatal vaccine education and in-office vaccination administration for non-birthing partners of pregnant patients increases Tdap vaccination rates compared to usual care.
The main question\[s\] it aims to answer are:
* To assess whether compared to standard prenatal care, targeted prenatal education regarding Tdap vaccination recommendat…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Partners of pregnant patients who are receiving their prenatal care at the OGCC
2. 19-50 years old: This age range was selected as 19 years is both the age at which adult Tdap vaccination is recommended by the CDC as well as the age for the State supplied adult Tdap and Influ…
Contacts